Evidence map›Paper›PMID 37089774›Full record

ArticleOpen forum infectious diseases2023

Patient and Epidemiological Factors Associated With Influenza Testing in Hospitalized Adults With Acute Respiratory Illnesses, 2016-2017 to 2019-2020.

Alexandra F Dalton, Alexia Couture, Malini B DeSilva, Stephanie A Irving, Shruti Gohil, Suchitra Rao, Rebecca V Fink, Allison L Naleway, Zijing Guo, Devi Sundaresan and 6 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Alexandra F DaltonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-3407-2961
Alexia CoutureInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-4257-3697
Malini B DeSilvaHealthPartners Institute, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0003-3705-1672
Stephanie A IrvingCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
Shruti GohilDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, California, USA.
Suchitra RaoDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Rebecca V FinkWestat, Rockville, Maryland, USA.
Allison L NalewayCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
Zijing GuoInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Devi SundaresanInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rebecca J BirchWestat, Rockville, Maryland, USA.
Sarah BallWestat, Rockville, Maryland, USA.
Kai ZhengDepartment of Informatics, University of California, Irvine, California, USA.
Toan C OngDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Carrie ReedInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-7944-7638
Catherine H BozioInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USWestat (United States) · USKaiser Permanente Center for Health Research · USUniversity of California, Irvine · USUniversity of Colorado Anschutz Medical Campus · USHealthPartners · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Data are limited on influenza testing among adults with acute respiratory illness (ARI)-associated hospitalizations. We identified factors associated with influenza testing in adult ARI-associated hospitalizations across the 2016-2017 through 2019-2020 influenza seasons. Methods: Using data from 4 health systems in the United States, we identified hospitalizations that had an ARI discharge diagnosis or respiratory virus test. A hospitalization with influenza testing was based on testing performed within 14 days before through 72 hours after admission. We used random forest analysis to identify patient characteristics and influenza activity indicators that were most important in terms of their relationship to influenza testing. Results: Across 4 seasons, testing rates ranged from 14.8%-19.4% at 3 pooled sites and 60.1%-78.5% at a fourth site with different testing practices. Discharge diagnoses of pneumonia or infectious disease of noninfluenza etiology, presence of ARI signs/symptoms, hospital admission month, and influenza-like illness activity level were consistently among the variables with the greatest relative importance. Conclusions: Select ARI diagnoses and indicators of influenza activity were the most important factors associated with influenza testing among ARI-associated hospitalizations. Improved understanding of which patients are tested may enhance influenza burden estimates and allow for more timely clinical management of influenza-associated hospitalizations.

Indexed as

acute respiratory illnessclinical testinghospitalizationinfluenza

Identifiers

PMID37089774
PMCPMC10117375
OpenAlexW4360939558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.